CBG Atlas

Safety & reporting
AtlasLabel Lab
Read a COAHow we gradeGap-Map
Working document · the label

Label Lab.

The jar makes promises; the ladder decides which words are allowed. A label claim is a sentence with a class, a hedge and, somewhere behind it, a grade. Write one in the checker, or pick one from its list, and it applies the rules this site applies to its own sentences: what kind of claim it is, whether it is hedged, whether it smuggles a researcher-tier number, and what our registry actually holds on the nearest topic.

Test a claim →How the check works
The checker

What the words are allowed to say.

The full result for the claim in the checker above: its class, its hedge, whether it carries a researcher-tier figure, and the three forms of wording that would survive. The grade chip is the same chip the rest of the site uses; a topic our registry holds no study on shows the dashed no-primary-evidence tag instead of a rung.

The claim is set in the checker at the top of the page. Change the claim

Claim under testSupports calm

Claim class
Structure-function-style effect claimIt asserts an effect or a benefit, in structure-function style.
Hedge
Absentmay · might · suggests · preliminary · preclinical
Potency value
NoneNo receptor-potency constant or per-kilogram dose in the text.
Closest graded topic
grade: LowCBG for anxiety and stressThe registry’s position, in its own words: In the only human trial of CBG's effects on anxiety and stress, a one-time 20 mg oral dose of CBG was associated with lower self-reported anxiety and stress in healthy adults, with no intoxication or measurable impairment.

VerdictAn effect claim on a question graded Low (“limited evidence · unclear”): an unclear result is not a label sentence, hedged or not. The registry's position stays on the dossier.

What would survive

The three forms a CBG label sentence can take, and which of them the nearest topic permits. Content is always writable; identity where the site documents one; the effect form only where the grade allows it.

Content form
Contains [amount] mg CBG per servingAlways writable. The label has to match the certificate of analysis: milligrams per serving, reconcilable to the panel once the serving size is applied.
Identity form
Non-intoxicatingDocumented on /monograph, in the CB1 record (Cascio et al., 2010): the compound itself is non-intoxicating, and the page's own FAQ answers the question with a plain no.Cascio 2010, PMID 20002104 · Read it on MONOGRAPH page →
Effect form
Not writable at this gradeNot writable at this grade. Low (“limited evidence · unclear”): an unclear result is not a label sentence. The registry's position stays on the dossier, not on the jar.Read it on CBG/ANXIETY page →
Copies the writable lines only, one per line. Everything else stays here with its reason.

Informational, not legal advice; label rules depend on jurisdiction and product class.

Cardiovascular note

A blood-pressure result in the checker is mechanistic and safety-relevant, not a benefit claim. CBG shows potent α2-adrenoceptor agonism in vitro, and α2 agonists can lower blood pressure — but no study has measured an actual blood-pressure effect of CBG. If you take blood-pressure medication or have a cardiovascular condition, consult a clinician first.

Method

How the check works.

The checker applies the same rules the site’s build applies to its own FAQ answers before they are published as structured data. An answer that asserts an effect with no grade or no hedge, or that carries a receptor-potency figure, is refused at build time; a label claim that does the same is refused here. There is one copy of the rules, imported here.

  1. Class. Proof, cure or approval language, or a cure-or-prevent verb beside a named condition, makes a disease claim. An effect verb on its own (help, reduce, support, calm, antibacterial) makes a structure-function-style effect claim. Anything else is an identity or content statement.
  2. Hedge. The site’s hedge list: may, might, suggests, preliminary, preclinical, in vitro and their kin. An effect claim without one is an unhedged health claim.
  3. Researcher-tier figures. Receptor-potency constants and per-kilogram doses appear only on researcher surfaces, never on a consumer page or a label.
  4. The nearest graded topic. Keywords route the claim to one of the registry’s condition dossiers, and the page quotes that dossier’s first sentence, unchanged. A claim that names another compound routes to that compound’s page instead: CBN and sleep, THCV and appetite, CBDV and seizures, and spectrum and the entourage effect, each quoted from its own knowledge-boundary row and labelled the way that page labels it, cited in prose and ungraded in the registry. The grade governs the verbs:
  5. What would survive. Three forms, always in the same order: the content form (milligrams per serving, which has to match the certificate), the identity form where the site documents one, and the effect form rewritten with the hedge bound to the rung. Low, Hypothesized, Not supported and no-primary-evidence topics get “not writable at this grade” with the reason, and so does every claim routed to another pillar.
Informational only

Informational, not legal advice; label rules depend on jurisdiction and product class. Nothing here is medical advice, and no result from the checker is a claim that CBG does anything for any condition. Read how we grade, then check the paperwork with Read a COA. Report a safety event. Peregrine Biopharma funds the platform and holds no editorial authority.